Open Nav

Tim Erickson, PhD

Chief Scientist


I am CEO & Chief Scientist of IngenoVax and the inventor of the Microbial Mimetics vaccine platform. Based partially on my own battle against cancer, I am profoundly interested in cancer immunotherapy and firmly believe that vaccines will become a major pillar of cancer therapy in the next 5-10 years. My long-term, overarching goal is to clinically develop and commercialize Microbial Mimetics for use in multiple indications, including colorectal, pancreatic, prostate, medullary thyroid, and non-small cell lung cancers, among potential others. I have diverse research background, which spans many fields, including nanomedicine, optics, semiconductor physics, interface chemistry, biomedical sensing, environmental sensing, genomics, and vaccine design. I hold multiple patents and several of my publications have been cited dozens of time. I am a capable and innovative researcher and have gained solid business sense via prior startup- and large corporate-experience.

This speaker's sessions: